Literature DB >> 2192993

ras-transformed NIH 3T3 cell lines, selected for metastatic ability in chick embryos, have increased proportions of p21-expressing cells and are metastatic in nude mice.

A F Chambers1, G H Denhardt, S M Wilson.   

Abstract

We previously reported that ras-transformed NIH 3T3 cells could be selected in vivo for increased metastatic ability after intravenous injection into chick embryos, and that the metastatic cell populations expressed increased levels of ras p21 protein. We have tested the metastatic ability of a series of these cells in nude mice, to determine if their properties in the chick embryo experimental metastasis assay predict their metastatic behavior in nude mice. We report here that cells selected for metastatic ability in the chick embryo are also metastatic when assayed in nude mice. We also asked whether the selected cells uniformly expressed higher levels of p21, using an immunocytochemical procedure. We found that p21 expression among individual cells in these populations was quite heterogeneous. There was a direct relationship between the proportions of p21-expressing cells and metastatic ability in both assays, with increased proportions of p21-expressing cells in cell lines selected for metastatic ability. Our results suggest that (a) the experimental (i.v.) metastasis assay in the chick embryo offers an efficient and cost-effective procedure for the identification and selection of cells that are also experimentally metastatic in nude mice, and (b) the metastatic properties of ras-transformed NIH 3T3 cells are due to individual cells that express increased amounts of p21.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2192993

Source DB:  PubMed          Journal:  Invasion Metastasis        ISSN: 0251-1789


  12 in total

1.  Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression.

Authors:  A F Chambers; G H Denhardt; S M Wilson; J G Cairncross
Journal:  J Neurooncol       Date:  1991-08       Impact factor: 4.130

2.  Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well.

Authors:  S Koop; E E Schmidt; I C MacDonald; V L Morris; R Khokha; M Grattan; J Leone; A F Chambers; A C Groom
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

Review 3.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

4.  Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling.

Authors:  Nicolas Aznar; Krishna K Midde; Ying Dunkel; Inmaculada Lopez-Sanchez; Yelena Pavlova; Arthur Marivin; Jorge Barbazán; Fiona Murray; Ulrich Nitsche; Klaus-Peter Janssen; Karl Willert; Ajay Goel; Miguel Abal; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  Elife       Date:  2015-06-30       Impact factor: 8.140

5.  ras transfection and expression does not induce progression from tumorigenicity to metastatic ability in mouse LTA cells.

Authors:  A B Tuck; S M Wilson; A F Chambers
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

6.  Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.

Authors:  R Kothapalli; N Guthrie; A F Chambers; K K Carroll
Journal:  Lipids       Date:  1993-11       Impact factor: 1.880

7.  Up-regulation of TIMP-1 expression in B16-F10 melanoma cells suppresses their metastatic ability in chick embryo.

Authors:  R Khokha; M J Zimmer; S M Wilson; A F Chambers
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

8.  Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

Authors:  A Bellahcène; V Castronovo
Journal:  Am J Pathol       Date:  1995-01       Impact factor: 4.307

9.  Osteopontin (OPN) may facilitate metastasis by protecting cells from macrophage NO-mediated cytotoxicity: evidence from cell lines down-regulated for OPN expression by a targeted ribozyme.

Authors:  B Feng; E E Rollo; D T Denhardt
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

10.  Identification of a ras-activated enhancer in the mouse osteopontin promoter and its interaction with a putative ETS-related transcription factor whose activity correlates with the metastatic potential of the cell.

Authors:  X Guo; Y P Zhang; D A Mitchell; D T Denhardt; A F Chambers
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.